Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Improved ejection fraction"'
Autor:
Jiachen Luo, Xiaoming Qin, Xingxu Zhang, Yiwei Zhang, Yuan Fang, Wentao Shi, Baoxin Liu, Yidong Wei, the NOAFCAMI‐SH Registry Investigators
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3713-3722 (2024)
Abstract Aims Improvement in left ventricular ejection fraction (impEF) often presents in contemporary acute myocardial infarction (AMI) patients. New‐onset atrial fibrillation (NOAF) during AMI is an important predictor of subsequential heart fail
Externí odkaz:
https://doaj.org/article/da60f62817324aa3b32e75ccac571cbd
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Heart failure with improved ejection fraction (HFimpEF) has been regarded as a new heart failure (HF) type in 2022. However, studies on the impact of left ventricular ejection fraction (LVEF) trajectories on the prognosis of patie
Externí odkaz:
https://doaj.org/article/5e0a3631feea4d579e98eb14a528ab05
Autor:
Chen Die Yang, Jin Wei Quan, Guan Poh Tay, Shuo Feng, He Yuan, Abulikemu Amuti, Si Yi Tang, Xin Rui Wu, Ruo Sen Yuan, Lin Lu, Rui Yan Zhang, Xiao Qun Wang
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Heart failure (HF) with improved ejection fraction (EF, HFimpEF) is a distinct HF subtype, characterized by left ventricular (LV) reverse remodeling and myocardial functional recovery. Multiple cardiometabolic factors are implicat
Externí odkaz:
https://doaj.org/article/417528fbc0034aa3a5261ade947339bd
Autor:
Kyung An Kim, Sang Hyun Kim, Kwan Yong Lee, Andrew H. Yoon, Byung‐Hee Hwang, Eun Ho Choo, Jin Jin Kim, Ik Jun Choi, Chan Joon Kim, Sungmin Lim, Mahn‐Won Park, Ki‐Dong Yoo, Doo Soo Jeon, Youngkeun Ahn, Myung Ho Jeong, Kiyuk Chang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 16 (2024)
Background Little is known about the characteristics and long‐term clinical outcomes of patients with heart failure with improved ejection fraction (HFimpEF) after acute myocardial infarction. Methods and Results From a multicenter, consecutive coh
Externí odkaz:
https://doaj.org/article/075025b922cf43b7906347a067e4691f
Autor:
Balázs Solymossi, Balázs Muk, Róbert Sepp, Tamás Habon, Attila Borbély, Krisztina Heltai, Zsuzsanna Majoros, Zoltán Járai, Dénes Vágány, Ákos Szatmári, Erzsébet Sziliczei, Fanni Bánfi‐Bacsárdi, Noémi Nyolczas
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 783-794 (2024)
Abstract Aims The aim of the study was to assess the incidence and predictive factors of the development of heart failure with improved ejection fraction (HFimpEF) category during a 1 year follow‐up period in a heart failure with reduced ejection f
Externí odkaz:
https://doaj.org/article/390d534829ba4d03a7f5916c0194032f
Autor:
Hyuk Kyoon Park, Jong Sung Park, Myeong Seop Kim, Eunkyu Lee, Hyohun Choi, Yoon Jung Park, Bo Eun Park, Hong Nyun Kim, Namkyun Kim, Myung Hwan Bae, Jang Hoon Lee, Hun Sik Park, Yongkeun Cho, Se Yong Jang, Dong Heon Yang
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3430-3437 (2023)
Abstract Aims The long‐term effect of angiotensin receptor–neprilysin inhibitor (ARNI) remains uncertain in patients who have experienced improvements in left ventricular (LV) systolic function or significant LV reverse remodelling following a ce
Externí odkaz:
https://doaj.org/article/4418d15f97ee48368c1a0e99076a1529
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 8, p 280 (2024)
Background: Heart failure with reduced ejection fraction (HFrEF) patients who have improved ejection fraction have a better prognosis than those with persistently reduced ejection fraction. This study aimed to analyze the predictors for progression o
Externí odkaz:
https://doaj.org/article/fbe98eba16d1461f9faacd9f4ccc75ca
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 270-276 (2023)
Heart failure and arrhythmias are pathogenetically closely interconnected and they are mutually aggravating each other. At the same time, tachycardia-induced cardiomyopathy is particularly a reversible disease with proper treatment. This article pres
Externí odkaz:
https://doaj.org/article/486252623ff5411b90f16375f537678c
Autor:
Dan Liu, Kai Hu, Lena Schregelmann, Clara Hammel, Björn Daniel Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1358-1371 (2023)
Abstract Aims This study aimed to investigate the prognostic value of dynamic changes in left ventricular ejection fraction (EF) for cardiovascular (CV) outcomes in an all‐comer heart failure (HF) population with reduced EF (HFrEF, EF 4 vs. ≤4 ye
Externí odkaz:
https://doaj.org/article/3c7bcf2ea6b64251a41caad674d05e16
Autor:
Elisabet Zamora, Beatriz González, Josep Lupón, Andrea Borrellas, Mar Domingo, Evelyn Santiago‐Vacas, Germán Cediel, Pau Codina, Carmen Rivas, Ana Pulido, Eva Crespo, Patricia Velayos, Violeta Diaz, Antoni Bayes‐Genis
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 3804-3813 (2022)
Abstract Aims The criteria for patients with heart failure (HF) and improved ejection fraction (HFimpEF) are a baseline left ventricular ejection fraction (LVEF) ≤40%, a ≥10‐point increase from baseline LVEF, and a second LVEF measurement >40%.
Externí odkaz:
https://doaj.org/article/71c62bd9ab3d4811bb333aa82b39e3c1